CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine.
about
CGRP as a neuropeptide in migraine: lessons from miceThe TRPA1 channel in migraine mechanism and treatmentTargeting TRP channels for novel migraine therapeutics.Chemical mediators of migraine: preclinical and clinical observations.Antidromic vasodilatation and the migraine mechanism.CGRP and NO in the trigeminal system: mechanisms and role in headache generation.Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience.Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies.Drugs targeting nitric oxide synthase for migraine treatment.CGRP antagonists and antibodies for the treatment of migraine.CGRP in human models of primary headaches.Functional Neuroimaging in Migraine: Chances and Challenges.Towards a pragmatic human migraine model for drug testing: 2. Isosorbide-5-mononitrate in healthy individuals.Brain natriuretic peptide constitutively downregulates P2X3 receptors by controlling their phosphorylation state and membrane localizationPharmacology of reflex blinks in the rat: a novel model for headache research.The calcitonin gene-related peptide receptor antagonist MK-8825 decreases spinal trigeminal activity during nitroglycerin infusion.Human models of migraine - short-term pain for long-term gain.Recurrent administration of the nitric oxide donor, isosorbide dinitrate, induces a persistent cephalic cutaneous hypersensitivity: A model for migraine progression.Toward a pragmatic migraine model for drug testing: 1. Cilostazol in healthy volunteersNitric oxide synthase, calcitonin gene-related peptide and NK-1 receptor mechanisms are involved in GTN-induced neuronal activation
P2860
Q26821821-E63F6272-DCE0-4227-A15E-01565BAEDED8Q27016641-4A5BFB23-8338-4119-BA4F-2221B8B8E8A7Q34555756-BD15176F-5979-4618-B5CE-6EB21102F94AQ37883455-1411163C-21A5-4A9A-AB82-1443B5224036Q37971447-955A9B46-475A-450A-BF7D-EC626AFF51ABQ38025661-A9152D7E-60A3-4FB2-94F5-3378598798E2Q38106681-4B17B06A-7C8B-4651-B5A8-B1C9F7E8AE19Q38130336-00A774EA-D350-49DF-808A-26CDA05CF1E6Q38211063-9659237C-85C8-47B6-BA4D-82C59CC395DBQ38248953-14D73170-0309-41BE-9313-D49747777367Q38784420-EFCFC260-6745-461C-BE86-96780F9AA0E7Q38818899-13932120-AE00-4B7B-B3A3-0DF30926953EQ38902228-E93FC5CF-744D-448D-91BA-91400014EB8AQ38942004-E084AA54-0EAD-4A7C-94BE-1CFB7870173BQ41536750-455B53FC-C923-48FA-BD86-83AE37AF8B94Q41829270-B65F2D37-3742-4ECB-AD46-4EDDB49EDF63Q47912532-02226DB4-AFAB-48E9-B960-908D7E3BB1CEQ53599526-E2F41E7D-408B-43F2-A2E9-646B226699A3Q57023753-54583AAA-9C44-4A05-8761-7DA5E8E5F848Q57023856-D1ED1FD0-8045-441B-8060-96E7C738124B
P2860
CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
CGRP receptor antagonist olceg ...... l trinitrate-induced migraine.
@en
CGRP receptor antagonist olcegepant
@nl
type
label
CGRP receptor antagonist olceg ...... l trinitrate-induced migraine.
@en
CGRP receptor antagonist olcegepant
@nl
prefLabel
CGRP receptor antagonist olceg ...... l trinitrate-induced migraine.
@en
CGRP receptor antagonist olcegepant
@nl
P2860
P50
P356
P1433
P1476
CGRP receptor antagonist olceg ...... yl trinitrate-induced migraine
@en
P2093
L T Jensen
P Tfelt-Hansen
P2860
P304
P356
10.1177/0333102410363491
P407
P577
2010-04-07T00:00:00Z